Retrospective cohort study identifying mGPS 2 as a time-dependent predictor of overall survival in advanced gastric cancer, but with modest sample size, observational design, and no practice-changing effect size or mechanistic clarity.
A single case report of advanced HCC with rupture treated with combination immunotherapy and successfully transplanted; demonstrates feasibility but lacks comparator, control group, and generalizability needed to establish efficacy or change practice.
Single-centre retrospective study with modest sample size identifies ALBI score as prognostic for survival after TARE, but lacks prospective design, external validation, and mechanistic insight into clinical benefit.